Implantable chemotherapy-loaded silk protein materials for neuroblastoma treatment-Reference-Cited by-同舟云学术

Implantable chemotherapy-loaded silk protein materials for neuroblastoma treatment

Published:2016-11-03 Issue:3 Volume:140 Page:726-735
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Coburn Jeannine¹,Harris Jamie²,Zakharov Alexander D.³,Poirier Jennifer⁴,Ikegaki Naohiko⁵,Kajdacsy-Balla Andre⁶,Pilichowska Monika⁷,Lyubimov Alexander V.³,Shimada Hiroyuki⁸,Kaplan David L.¹,Chiu Bill²

Affiliation:

1. Department of Biomedical Engineering; Tufts University; 4 Colby Street Medford MA

2. Department of Surgery; University of Illinois at Chicago; 840 S. Wood Street Chicago IL

3. Department of Pharmacology, Toxicology Research Laboratory; 808 S Wood Street Chicago IL

4. Department of Surgery; Rush University; 1653 W. Congress Parkway Chicago IL

5. Department of Anatomy and Cell Biology; University of Illinois at Chicago; 808 S. Wood Street Chicago IL

6. Department of Pathology; University of Illinois at Chicago; 840 S. Wood Street Chicago IL

7. Department of Pathology; Tufts Medical Center; 800 Washington Street Boston MA

8. Department of Pathology; Children's Hospital of Los Angeles; 4650 Sunset Blvd Los Angeles CA

Funder

Warren and Clara Cole Career Development Award (American College of Surgeons), National Center for Advancing Translational Sciences, National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.30479/fullpdf

Reference38 articles.

1. Neuroblastoma;Maris;Lancet,2007

2. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment;Brodeur;J Clin Oncol,1993

3. Advances in the surgical treatment of neuroblastoma: a review;Murphy;Eur J Pediatr Surg,2014

4. Long-term survivors of childhood cancer: the late effects of therapy;Schwartz;Oncologist,1999

5. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma;Baker;N Engl J Med,2010

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Up-to-date Review on Protein-based Nanocarriers in the Management of Cancer;Current Drug Delivery;2024-05

2. Recent trends in controlled drug delivery based on silk platforms;Silk-Based Biomaterials for Tissue Engineering, Regenerative and Precision Medicine;2024

3. Concurrent application of interferon-gamma and vincristine inhibits tumor growth in an orthotopic neuroblastoma mouse model;Pediatric Surgery International;2023-07-27

4. Silk fibroin carriers with sustained release capacity for treating neurological diseases;Frontiers in Pharmacology;2023-05-05

5. Silk materials at the convergence of science, sustainability, healthcare, and technology;Applied Physics Reviews;2022-03